🇺🇸 FDA
Patent

US 10335423

Inhibition of HIV infection through chemoprophylaxis

granted A61KA61K31/513A61K31/675

Quick answer

US patent 10335423 (Inhibition of HIV infection through chemoprophylaxis) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jun 27 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jul 02 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 27 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/513, A61K31/675, A61K31/683, A61K31/7072